New Delhi, March 31: India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its development, according to a report released on Tuesday. This is due to strong policy support and a growing pipeline of innovation.The report by Endiya Partners said that the...
bioeconomy
biopharmaceuticals
biotech
clinical trials
drug development
gmp infrastructure
government funding
healthcare
india
innovation
pharmaceuticals
policy
r&d
research institutes
startup ecosystem
India’s Bioeconomy Surges to $195 Billion, Aiming for $300 Billion by 2030
New Delhi, March 19 – India’s bioeconomy has witnessed remarkable growth, expanding to over $195 billion by 2025 from approximately $10 billion in 2014, Union Minister Dr Jitendra Singh stated on Thursday.Speaking at...
